Results

1–10 of 410 results for AMD

Novel Handheld Device for Remote Monitoring of Non-neovascular Age-Related Macular Degeneration andClinical Validation of Usability and Comfort
Yannis M Paulus, MD
Annual Meeting Talks
2025
Genotype Prediction From Retinal Fundus Images Using Deep Learning in Eyes With Age-Related MacularDegeneration
Glenn C. Yiu, MD, PhD
Annual Meeting Talks
2025
New Data Analyses on Whether AREDS Patients Should Have Routine Genetic Testing
Stephen R. Kaufman, MD
Annual Meeting Talks
2025
Impact of AREDS Oral Micronutrient Supplementation on Geographic Atrophy Progression: Insights From thePhase 3 OAKS and DERBY Trials
Paul Hahn, MD, PhD, FASRS
Annual Meeting Talks
2025
LIGHTSITE IIIB: A Prospective, Multi-Center Extension Study to Assess the Long-Term Safety and Efficacy ofPhotobiomodulation in Dry Age-Related Macular Degeneration
David S. Boyer, MD
Annual Meeting Talks
2025
ARCHER II, a Phase 3 Randomized Clinical Trial of ANX007 in Patients With Dry AMD and GA: Study Design andRationale Informed by Outcomes From ARCHER
David A. Eichenbaum, MD, FASRS
Annual Meeting Talks
2025
The 12-Month Safety Results of the PRIMAvera Clinical Trial
Lisa C. Olmos de Koo, MD, MBA
Annual Meeting Talks
2025
Progression of Geographic Atrophy in Patients Receiving Both Anti-VEGF and Pegcetacoplan Injections
Sean David Adrean, MD, FAAO, FASRS
Annual Meeting Talks
2025
Safety Profiles of Combined Anticomplement and Anti-VEGF Intravitreal Therapies for Age-Related MacularDegeneration From Real-World Data
Edward H. Wood, MD, FASRS
Annual Meeting Talks
2025
A Descriptive Analysis of Patients Who Received Pegcetacoplan and Anti-VEGF for the Treatment ofGeographic Atrophy and Neovascular AMD
Nimesh A. Patel, MD
Annual Meeting Talks
2025